Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignanciesArno J. Mundt, John C. Roeske, S. Diane Yamada et al.|International Journal of Radiation Oncology*Biology*Physics|2002Cited by 468
Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapyLoren K. Mell, Arno J. Mundt, S. Diane Yamada et al.|International Journal of Radiation Oncology*Biology*Physics|2006Cited by 331
c-Met Overexpression Is a Prognostic Factor in Ovarian Cancer and an Effective Target for Inhibition of Peritoneal Dissemination and InvasionKenjiro Sawada, Ernst Lengyel, Ravi Salgia et al.|Cancer Research|2007Cited by 260
Impact of intensity-modulated radiotherapy on acute hematologic toxicity in women with gynecologic malignanciesClark J Brixey, Arno J. Mundt, John C. Roeske et al.|International Journal of Radiation Oncology*Biology*Physics|2002Cited by 247
Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapyAnthony E. Lujan, John C. Roeske, Arno J. Mundt et al.|International Journal of Radiation Oncology*Biology*Physics|2003Cited by 189